Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone.

Dugan JP, Haverkos BM, Villagomez L, Martin LK, Lustberg M, Patton J, Martin M, Huang Y, Nuovo G, Yan F, Cavaliere R, Fingeroth J, Kenney SC, Ambinder RF, Lozanski G, Porcu P, Caligiuri MA, Baiocchi RA.

Clin Cancer Res. 2018 Jul 15;24(14):3273-3281. doi: 10.1158/1078-0432.CCR-17-2685. Epub 2018 Apr 9.

2.

A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events.

Erskine N, Tran H, Levin L, Ulbricht C, Fingeroth J, Kiefe C, Goldberg RJ, Singh S.

PLoS One. 2017 Jul 27;12(7):e0181565. doi: 10.1371/journal.pone.0181565. eCollection 2017. Review.

3.

Epstein-Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation.

Hu H, Luo ML, Desmedt C, Nabavi S, Yadegarynia S, Hong A, Konstantinopoulos PA, Gabrielson E, Hines-Boykin R, Pihan G, Yuan X, Sotiriou C, Dittmer DP, Fingeroth JD, Wulf GM.

EBioMedicine. 2016 Jul;9:148-160. doi: 10.1016/j.ebiom.2016.05.025. Epub 2016 May 21.

4.

Inherited CHST11/MIR3922 deletion is associated with a novel recessive syndrome presenting with skeletal malformation and malignant lymphoproliferative disease.

Chopra SS, Leshchiner I, Duzkale H, McLaughlin H, Giovanni M, Zhang C, Stitziel N, Fingeroth J, Joyce RM, Lebo M, Rehm H, Vuzman D, Maas R, Sunyaev SR, Murray M, Cassa CA.

Mol Genet Genomic Med. 2015 Sep;3(5):413-23. doi: 10.1002/mgg3.152. Epub 2015 May 10.

5.

A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice.

Ogembo JG, Muraswki MR, McGinnes LW, Parcharidou A, Sutiwisesak R, Tison T, Avendano J, Agnani D, Finberg RW, Morrison TG, Fingeroth JD.

J Transl Med. 2015 Feb 6;13:50. doi: 10.1186/s12967-015-0415-2.

6.

Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection.

Arredouani MS, Bhasin MK, Sage DR, Dunn LK, Gill MB, Agnani D, Libermann TA, Fingeroth JD.

J Virol. 2014 May;88(10):5559-77. doi: 10.1128/JVI.03099-13. Epub 2014 Mar 5.

7.

Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells.

Sun X, Bristol JA, Iwahori S, Hagemeier SR, Meng Q, Barlow EA, Fingeroth JD, Tarakanova VL, Kalejta RF, Kenney SC.

J Virol. 2013 Sep;87(18):10126-38. doi: 10.1128/JVI.01671-13. Epub 2013 Jul 10.

8.

Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor.

Ogembo JG, Kannan L, Ghiran I, Nicholson-Weller A, Finberg RW, Tsokos GC, Fingeroth JD.

Cell Rep. 2013 Feb 21;3(2):371-85. doi: 10.1016/j.celrep.2013.01.023. Epub 2013 Feb 14.

9.

SIRPĪ±/CD172a and FHOD1 are unique markers of littoral cells, a recently evolved major cell population of red pulp of human spleen.

Ogembo JG, Milner DA Jr, Mansfield KG, Rodig SJ, Murphy GF, Kutok JL, Pinkus GS, Fingeroth JD.

J Immunol. 2012 May 1;188(9):4496-505. doi: 10.4049/jimmunol.1103086. Epub 2012 Apr 4.

10.

Comparative binding of soluble fragments (derCD23, sCD23, and exCD23) of recombinant human CD23 to CD21 (SCR 1-2) and native IgE, and their effect on IgE regulation.

Bowles SL, Jaeger C, Ferrara C, Fingeroth J, Van De Venter M, Oosthuizen V.

Cell Immunol. 2011;271(2):371-8. doi: 10.1016/j.cellimm.2011.08.003. Epub 2011 Aug 12.

PMID:
21889131
11.

The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.

Meng Q, Hagemeier SR, Fingeroth JD, Gershburg E, Pagano JS, Kenney SC.

J Virol. 2010 May;84(9):4534-42. doi: 10.1128/JVI.02487-09. Epub 2010 Feb 24.

12.

What is your neurologic diagnosis? Primary malignant glioma with secondary necrosis and mass effect.

Fingeroth JM, Gavin PR, Rowland PH.

J Am Vet Med Assoc. 2007 Sep 1;231(5):703-5. No abstract available.

PMID:
17764426
13.

Views design of cranial cruciate ligament disease study as flawed.

Fingeroth JM.

Am J Vet Res. 2007 May;68(5):458; author reply 458. No abstract available.

PMID:
17472442
14.

Epstein-Barr virus thymidine kinase is a centrosomal resident precisely localized to the periphery of centrioles.

Gill MB, Kutok JL, Fingeroth JD.

J Virol. 2007 Jun;81(12):6523-35. Epub 2007 Apr 11.

15.

Intraoperative use of ultrasonography during continuous dorsal laminectomy in 2 dogs with caudal cervical vertebral instability and malformation ('Wobbler syndrome').

Fingeroth JM.

Vet Surg. 2006 Dec;35(8):793-4; author reply 794-5; discussion 795-6. No abstract available.

PMID:
17187644
16.

A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

Perrine SP, Hermine O, Small T, Suarez F, O'Reilly R, Boulad F, Fingeroth J, Askin M, Levy A, Mentzer SJ, Di Nicola M, Gianni AM, Klein C, Horwitz S, Faller DV.

Blood. 2007 Mar 15;109(6):2571-8. Epub 2006 Nov 21.

17.

Retention of surgery specialists in academia: a critical agenda.

Adams SB, Schulz K, Hardy J, Bliss S, Lipowitz A, Baxter G, Meagher D, Fingeroth J, Howe L, Grant B, Probst C, Loew A.

J Vet Med Educ. 2005 Winter;32(4):404-15.

PMID:
16421820
18.

Questions justification for inoculation of dogs.

Fingeroth JM.

Am J Vet Res. 2005 Dec;66(12):2018. No abstract available.

PMID:
16379640
20.

Effect of cisterna chyli ablation combined with thoracic duct ligation on abdominal lymphatic drainage.

Fingeroth JM.

Vet Surg. 2005 May-Jun;34(3):295; author reply 295. No abstract available.

PMID:
16115090
21.

Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection.

Zhang X, Wang JF, Chandran B, Persaud K, Pytowski B, Fingeroth J, Groopman JE.

J Biol Chem. 2005 Jul 15;280(28):26216-24. Epub 2005 May 4.

22.

Questions terminology in feline sporotrichosis article.

Fingeroth JM.

J Am Vet Med Assoc. 2004 Jul 1;225(1):32; author reply 32. No abstract available.

PMID:
15239469
23.

Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus.

Hong YK, Foreman K, Shin JW, Hirakawa S, Curry CL, Sage DR, Libermann T, Dezube BJ, Fingeroth JD, Detmar M.

Nat Genet. 2004 Jul;36(7):683-5. Epub 2004 Jun 27.

PMID:
15220917
24.

EBV attachment stimulates FHOS/FHOD1 redistribution and co-aggregation with CD21: formin interactions with the cytoplasmic domain of human CD21.

Gill MB, Roecklein-Canfield J, Sage DR, Zambela-Soediono M, Longtine N, Uknis M, Fingeroth JD.

J Cell Sci. 2004 Jun 1;117(Pt 13):2709-20. Epub 2004 May 11.

25.
26.
27.

The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding.

Prota AE, Sage DR, Stehle T, Fingeroth JD.

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10641-6. Epub 2002 Jul 16.

28.

Herpesvirus infection of the liver.

Fingeroth JD.

Infect Dis Clin North Am. 2000 Sep;14(3):689-719. Review.

PMID:
10987116
30.

Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate.

Oram RJ, Marcellino D, Strauss D, Gustafson E, Talarico CL, Root AK, Sharma PL, Thompson K, Fingeroth JD, Crumpacker C, Herold BC.

J Infect Dis. 2000 Apr;181(4):1458-61. Epub 2000 Apr 13.

PMID:
10762577
32.

Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak.

Marshall WL, Yim C, Gustafson E, Graf T, Sage DR, Hanify K, Williams L, Fingeroth J, Finberg RW.

J Virol. 1999 Jun;73(6):5181-5.

33.

Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells.

Chauhan D, Bharti A, Raje N, Gustafson E, Pinkus GS, Pinkus JL, Teoh G, Hideshima T, Treon SP, Fingeroth JD, Anderson KC.

Blood. 1999 Mar 1;93(5):1482-6.

PMID:
10029574
34.

CD21-Dependent infection of an epithelial cell line, 293, by Epstein-Barr virus.

Fingeroth JD, Diamond ME, Sage DR, Hayman J, Yates JL.

J Virol. 1999 Mar;73(3):2115-25.

37.

Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma.

Mentzer SJ, Fingeroth J, Reilly JJ, Perrine SP, Faller DV.

Blood Cells Mol Dis. 1998 Jun;24(2):114-23.

PMID:
9628848
38.

IGIV: a potential role for hepatitis B prophylaxis in the bone marrow peritransplant period.

Daily J, Werner B, Soiffer R, Fingeroth J.

Bone Marrow Transplant. 1998 Apr;21(7):739-42.

39.

Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon.

Vance EA, Soiffer RJ, McDonald GB, Myerson D, Fingeroth J, Ritz J.

Transplantation. 1996 Nov 15;62(9):1358-60.

PMID:
8932286
40.

Immunoblastic lymphoma of donor origin in the allograft after lung transplantation.

Mentzer SJ, Longtine J, Fingeroth J, Reilly JJ, DeCamp MM, O'Donnell W, Swanson SJ, Faller DV, Sugarbaker DJ.

Transplantation. 1996 Jun 27;61(12):1720-5.

PMID:
8685950
41.

Dorsal laminectomy.

Fingeroth JM.

J Am Anim Hosp Assoc. 1996 May-Jun;32(3):186-7. No abstract available.

PMID:
8731130
42.

Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells.

Kuhn-Hallek I, Sage DR, Stein L, Groelle H, Fingeroth JD.

Blood. 1995 Mar 1;85(5):1289-99.

PMID:
7858259
43.

Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course.

Shuhart MC, Myerson D, Childs BH, Fingeroth JD, Perry JJ, Snyder DS, Spurgeon CL, Bevan CA, McDonald GB.

Blood. 1994 Nov 1;84(9):3229-35.

PMID:
7949194
44.

Pacemaker therapy for bradycardias.

Fingeroth JM.

Semin Vet Med Surg (Small Anim). 1994 Nov;9(4):192-9. Review. No abstract available.

PMID:
7839028
45.

Zygomycosis due to Mucor circinelloides in a neutropenic patient receiving chemotherapy for acute myelogenous leukemia.

Fingeroth JD, Roth RS, Talcott JA, Rinaldi MG.

Clin Infect Dis. 1994 Jul;19(1):135-7.

PMID:
7948514
46.

Role of interleukin 6 in the growth of myeloma-derived cell lines.

Barut BA, Zon LI, Cochran MK, Paul SR, Chauhan D, Mohrbacher A, Fingeroth J, Anderson KC.

Leuk Res. 1992 Oct;16(10):951-9.

PMID:
1405708
47.

Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.

Freeman GJ, Gray GS, Gimmi CD, Lombard DB, Zhou LJ, White M, Fingeroth JD, Gribben JG, Nadler LM.

J Exp Med. 1991 Sep 1;174(3):625-31.

48.
49.

Fenestration. Pros and cons.

Fingeroth JM.

Probl Vet Med. 1989 Jul-Sep;1(3):445-66. Review.

PMID:
2520126
50.

Proliferation of resting B cells is modulated by CR2 and CR1.

Fingeroth JD, Heath ME, Ambrosino DM.

Immunol Lett. 1989 Jun 15;21(4):291-301.

PMID:
2527816

Supplemental Content

Loading ...
Support Center